Tumor markers in bladder cancer.
D000017:ABO Blood-Group System / Q000276:immunology; D000951:Antigens, Neoplasm / Q000032:analysis; D000954:Antigens, Surface / Q000032:analysis; D015295:Antigens, Tumor-Associated, Carbohydrate; D002272:Carcinoembryonic Antigen / Q000032:analysis; D002448:Cell Adhesion; D004187:Disaccharides / Q000032:analysis; D004912:Erythrocytes / Q000276:immunology; D005188:False Negative Reactions; D005338:Fibrin Fibrinogen Degradation Products / Q000652:urine; D006801:Humans; D007124:Immunoenzyme Techniques; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis* / Q000276:immunology
D000017:ABO Blood-Group System; D000951:Antigens, Neoplasm; D000954:Antigens, Surface; D015295:Antigens, Tumor-Associated, Carbohydrate; D002272:Carcinoembryonic Antigen; D004187:Disaccharides; D005338:Fibrin Fibrinogen Degradation Products; C016467:Thomsen-Friedenreich antigen